Chiquita Brooks-LaSure, the administrator for the Centers of Medicare and Medicaid Services (AP Photo/Evan Vucci)

CMS ex­plains how it will ne­go­ti­ate the most ex­pen­sive drug prices with bio­phar­ma be­gin­ning in 2026

The Cen­ters for Medicare and Med­ic­aid Ser­vices (CMS) late Wednes­day pub­lished its first long-await­ed guid­ance on how ex­act­ly bio­phar­ma com­pa­nies will have to ne­go­ti­ate with …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA